Composition of intraperitoneally implanted electrospun conduits modulates cellular elastic matrix generation
Source abstract
Abstract
Improving elastic matrix generation is critical to developing functional tissue engineered vascular grafts. Therefore, this study pursued a strategy to grow autologous tissue in vivo by recruiting potentially more elastogenic cells to conduits implanted within the peritoneal cavity. The goal was to determine the impacts of electrospun conduit composition and hyaluronan oligomer (HA-o) modification on the recruitment of peritoneal cells, and their phenotype and ability to synthesize elastic matrix. These responses were assessed as a function of conduit intra-peritoneal implantation time. This study showed that the blending of collagen with poly(ε-caprolactone) (PCL) promotes a faster wound healing response, as assessed by trends in expression of macrophage and smooth muscle cell (SMC) contractile markers and in matrix deposition, compared to the more chronic response for PCL alone. This result, along with the increase in elastic matrix production, demonstrates the benefits of incorporating as little as 25% w/w collagen into the conduit. In addition, PCR analysis demonstrated the challenges in differentiating between a myofibroblast and an SMC using traditional phenotypic markers. Finally, the impact of the tethered HA-o is limited within the inflammatory environment, unlike the significant response found previously in vitro. In conclusion, these results demonstrate the importance of both careful control of implanted scaffold composition and the development of appropriate delivery methods for HA-o.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Intestinal and Peritoneal Adhesions · Hernia repair and management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature10.1016/j.ejvs.2003.12.027 ↗
2. Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly10.1089/ten.teb.2011.0521 ↗
3. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs)10.1096/fj.07-087924 ↗
4. Elastic fibres10.1242/jcs.115.14.2817 ↗
5. Mori G. Role of the extracellular matrix in age-related modifications of the rat aorta. Ultrastructural, morphometric, and enzymatic evaluations10.1161/01.ATV.12.9.1008 ↗
6. Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells10.1089/ten.tea.2008.0593 ↗
7. Aligned electrospun scaffolds and elastogenic factors for vascular cell-mediated elastic matrix assembly10.1002/term.470 ↗
8. Insulin-like growth factor-I regulates transcription of the elastin gene10.1016/S0021-9258(18)31406-6 ↗
9. Macrophage phenotype as a determinant of biologic scaffold remodeling10.1089/ten.tea.2007.0264 ↗
10. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery10.33549/physiolres.931918 ↗
11. Applying elastic fibre biology in vascular tissue engineering10.1098/rstb.2007.2134 ↗
12. Decreased elastin synthesis in normal development and in long-term aortic organ and cell cultures is related to rapid and selective destabilization of mRNA for elastin10.1161/01.RES.77.6.1107 ↗
13. Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells10.1007/BF02620921 ↗
14. Mesenchymal stem cells attenuate angiotensin II-induced aortic aneurysm growth in apolipoprotein E-deficient mice10.1016/j.jvs.2011.06.109 ↗
15. Novel vascular graft grown within recipient’s own peritoneal cavity10.1161/01.RES.85.12.1173 ↗
16. Bioengineered vascular graft grown in the mouse peritoneal cavity10.1016/j.jvs.2010.05.015 ↗
17. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts10.1016/j.jvs.2003.03.003 ↗
18. Gene expression profile of the fibrotic response in the peritoneal cavity10.1016/j.diff.2010.03.001 ↗
19. Impact of electrospun conduit fiber diameter and enclosing pouch pore size on vascular constructs grown within rat peritoneal cavities10.1089/ten.tea.2012.0309 ↗
20. Elastic fiber production in cardiovascular tissue-equivalents10.1016/S0945-053X(03)00052-0 ↗
21. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering10.1016/S0142-9612(03)00374-0 ↗
22. Hyaluronic acid cues for functional endothelialization of vascular constructs10.1002/term.61 ↗
23. Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: physical, chemical, and theoretical aspects10.1021/bm0343040 ↗
24. Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(D, L-lactic-co-glycolic acid) meshes10.1016/j.biomaterials.2006.07.005 ↗
25. Effect of fiber diameter and alignment of electrospun polyurethane meshes on mesenchymal progenitor cells10.1089/ten.tea.2008.0295 ↗
26. Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells10.1089/ten.tea.2008.0040 ↗
27. A kinetic-based sigmoidal model for the polymerase chain reaction and its application to high-capacity absolute quantitative real-time PCR10.1186/1472-6750-8-47 ↗
28. Leigh DR, Mesiha M, Baker AR, Walker E, Derwin KA. Host response to xenograft ECM implantation is not different between the shoulder and body wall sites in the rat model. J Orthop Res 2012.10.1002/jor.22149 ↗
29. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR10.1093/bioinformatics/bth254 ↗
30. Tissue-engineered blood vessels: alternative to autologous grafts?10.1161/01.ATV.0000158996.03867.72 ↗
31. A simple, rapid, and sensitive DNA assay procedure10.1016/0003-2697(80)90165-7 ↗
32. Determination of hydroxyproline10.1016/0009-8981(67)90167-2 ↗
33. Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells10.1016/j.biomaterials.2006.01.020 ↗
34. Biological characterization of EDC-crosslinked collagen-hyaluronic acid matrix in dermal tissue restoration10.1016/S0142-9612(02)00550-1 ↗
35. Peritoneal healing and adhesion formation/reformation10.1093/humupd/7.6.556 ↗
36. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion10.1161/01.ATV.0000199393.74656.4c ↗
37. Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells10.1016/j.biomaterials.2007.05.019 ↗
38. Hyaluronan oligosaccharides promote functional recovery after spinal cord injury in rats10.1016/j.neulet.2010.11.051 ↗
39. Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells10.1016/j.biomaterials.2006.07.020 ↗
40. Growth factor delivery through electrospun nanofibers in scaffolds for tissue engineering applications10.1002/jbm.a.32645 ↗
41. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype10.1006/excr.1993.1016 ↗
42. Elastin production by cultured calf pulmonary artery endothelial cells10.1002/jcp.1041160304 ↗
43. The enzymatic degradation of scaffolds and their replacement by vascularized extracellular matrix in the murine myocardium10.1016/j.biomaterials.2005.11.002 ↗